Correlation Between Johnson Johnson and Corbus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Corbus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Corbus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Corbus Pharmaceuticals Holding, you can compare the effects of market volatilities on Johnson Johnson and Corbus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Corbus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Corbus Pharmaceuticals.
Diversification Opportunities for Johnson Johnson and Corbus Pharmaceuticals
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Johnson and Corbus is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Corbus Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corbus Pharmaceuticals and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Corbus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corbus Pharmaceuticals has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Corbus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Johnson Johnson and Corbus Pharmaceuticals
Considering the 90-day investment horizon Johnson Johnson is expected to under-perform the Corbus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Johnson Johnson is 14.18 times less risky than Corbus Pharmaceuticals. The stock trades about -0.01 of its potential returns per unit of risk. The Corbus Pharmaceuticals Holding is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 387.00 in Corbus Pharmaceuticals Holding on August 26, 2024 and sell it today you would earn a total of 1,360 from holding Corbus Pharmaceuticals Holding or generate 351.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Johnson Johnson vs. Corbus Pharmaceuticals Holding
Performance |
| Timeline |
| Johnson Johnson |
| Corbus Pharmaceuticals |
Johnson Johnson and Corbus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Johnson Johnson and Corbus Pharmaceuticals
The main advantage of trading using opposite Johnson Johnson and Corbus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Corbus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corbus Pharmaceuticals will offset losses from the drop in Corbus Pharmaceuticals' long position.| Johnson Johnson vs. Capricor Therapeutics | Johnson Johnson vs. Akari Therapeutics PLC | Johnson Johnson vs. Soleno Therapeutics | Johnson Johnson vs. Bio Path Holdings |
| Corbus Pharmaceuticals vs. Trevi Therapeutics | Corbus Pharmaceuticals vs. Cue Biopharma | Corbus Pharmaceuticals vs. AN2 Therapeutics | Corbus Pharmaceuticals vs. Bioatla |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |